Highlights AstraZeneca PLC Nasdaq Stockholm

Equities

Real-time Estimate Cboe Europe Other stock markets 10:04:32 24/05/2024 BST			5-day change	1st Jan Change
1,676 ^SEK	-1.11%		+1.79%	+23.61%

02:07am	Adherium Partners with AstraZeneca for Hailie Smartinhaler Trial	MT
05-23	AstraZeneca: licensing agreement signed with Nona Biosciences	CF

Adherium Partners with AstraZeneca for Hailie Smartinhaler Trial	01:07am	MT
HBM Holdings Unit, AstraZeneca Sign License, Option Agreement for Targeted Cancer Treatment; Shares Rise 16%	05-23	MT
AstraZeneca to present new oncology data	05-22	CF
US Equity Indexes Little Changed as Fed Officials Pepper Views on Policy Path, Investors Brace for Nvdia's Earnings	05-21	MT
US Equity Indexes Slightly Higher in Midday Trading	05-21	MT
European Equities Close Lower in Tuesday Trading; AstraZeneca Targets $80 Billion in Revenue by 2030	05-21	MT
London's FTSE 100 closes at one week-low ahead of CPI data	05-21	RE
European Equities Traded in the US as American Depositary Receipts Trend Modestly Higher in Tuesday Trading	05-21	MT
Sector Update: Health Care Stocks Steady Premarket Tuesday	05-21	MT
News Highlights : Top Company News of the Day - Tuesday at 9 AM ET	05-21	DJ
AstraZeneca says building China supply chain amid US-China tensions	05-21	RE
AstraZeneca aims for $80 bln in total revenue by 2030	05-21	RE
News Highlights : Top Company News of the Day - Tuesday at 7 AM ET	05-21	DJ
Stocks fall but pound up as IMF ups UK forecast	05-21	AN
Stocks fall but pound up as IMF ups UK forecast	05-21	AN
AstraZeneca Targets $80 Billion Revenue by 2030, Expects to Launch 20 New Medicines	05-21	MT
AstraZeneca aims to deliver $80 billion in total revenue by 2030	05-21	RE
AstraZeneca eyes new era of growth with bold new revenue aim	05-21	AN
AstraZeneca Targets $80 Billion Revenue by 2030	05-21	MT
AstraZeneca aims for $80 bln in total revenue by 2030	05-21	RE

No results for this search

ASTRAZENECA : Strong Q1 raises hopes of a guidance upgrade

April 25, 2024 at 05:02 pm